Characterization of human cellular immune responses to Mycobacterium tuberculosis proteins encoded by genes predicted in RD15 genomic region that is absent in Mycobacterium bovis BCG

FEMS Immunology and Medical Microbiology

Volumn 59, Issue 2, 2010, Pages 177-187

  Al Attiyah, Raja'a ^a   Mustafa, Abu Salim ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Anti inflammatory cytokines; Antigen induced proliferation; Mycobacterium tuberculosis; Peripheral blood mononuclear cells; RD15 proteins; Th1

Indexed keywords

BACTERIAL PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; MYCOBACTERIUM ANTIGEN; RD15 PROTEIN; RD1504 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIAL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; FLOW CYTOMETRY; GENETIC CODE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OPEN READING FRAME; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TH1 CELL; CELL CULTURE; CELL PROLIFERATION; GENETICS; IMMUNOLOGY; MONONUCLEAR CELL; SECRETION (PROCESS);

BACTERIAL PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; TH1 CELLS;

EID: 77953575196     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2010.00677.x     Document Type: Article

References (49)

1. Ahmad S, El-Shazly S, Mustafa AS Al-Attiyah R (2004) Mammalian cell-entry proteins encoded by the mce3 operon of Mycobacterium tuberculosis are expressed during natural infection in humans. Scand J Immunol 60 : 382-391.
2. Al-Attiyah R Mustafa AS (2008) Characterization of human cellular immune responses to novel Mycobacterium tuberculosis antigens encoded by genomic regions absent in Mycobacterium bovis BCG. Infect Immun 76 : 4190-4198.
3. Al-Attiyah R Mustafa AS (2009) Mycobacterial antigen-induced cell proliferation and Th1 and Th2 cytokine secretion by peripheral blood mononuclear cells of diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis BCG vaccinated healthy subjects. Clin Exp Immunol 158 : 64-73.
4. Al-Attiyah R, Shaban FA, Wiker HG, Oftung F Mustafa AS (2003) Synthetic peptides identify promiscuous human Th1 cell epitopes of the secreted mycobacterial antigen MPB70. Infect Immun 71 : 1953-1960.
5. Al-Attiyah R, Mustafa AS, Abal AT, El-Shamy AS, Dalemans W Skeiky YA (2004) In vitro cellular immune responses to complex and newly defined recombinant antigens of Mycobacterium tuberculosis. Clin Exp Immunol 138 : 139-144.
6. Al-Attiyah R, El-Shazly A Mustafa AS (2006a) Assessment of in vitro immunity to Mycobacterium tuberculosis in a human peripheral blood infection model using a luciferase reporter construct of M. tuberculosis H37Rv. Clin Exp Immunol 145 : 520-527.
7. Al-Attiyah R, Madi N, El-Shamy AS, Wiker H, Andersen P Mustafa AS (2006b) Cytokine profiles in tuberculosis patients and healthy subjects in response to complex and single antigens of Mycobacterium tuberculosis. FEMS Immunol Med Mic 47 : 254-261.
8. Bai X, Wilson SE, Chmura K, Feldman NE Chan ED (2004) Morphometric analysis of Th(1) and Th(2) cytokine expression in human pulmonary tuberculosis. Tuberculosis 84 : 375-385.
9. Behr MA, Wilson MA, Gill WP, Salamon H, Schoolnik GK, Rane S Small PM (1999) Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284 : 1520-1523.
10. Brock I, Weldingh K, Leyten EMS, Arend SM, Ravn P Andersen P (2004) Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection. J Clin Microbiol 42 : 2379-2387.
11. Brosch R, Gordon SV, Pym A, Eiglmeier K, Garnier T Cole ST (2000) Comparative genomics of the mycobacteria. Int J Med Microbiol 290 : 143-152.
12. Crampin AC, Glynn JR Fine PE (2009) What has Karonga taught us? Tuberculosis studied over three decades. Int J Tuberc Lung D 13 : 153-164.
13. Dietrich J, Weldingh K Andersen P (2006) Prospects for a novel vaccine against tuberculosis. Vet Microbiol 112 : 163-169.
14. El-Shazly S, Ahmad S, Mustafa AS, Al-Attiyah R Krajci D (2007) Internalization by HeLa cells of latex beads coated with mammalian cell entry (Mce) proteins encoded by the mce3 operon of Mycobacterium tuberculosis. J Med Microbiol 56 : 1145-1151.
15. Flynn J (2004) Immunology of tuberculosis and implications in vaccine development. Tuberculosis 4 : 93-101.
16. Gioffré A, Infante E, Aguilar D et al. 2005) Mutation in mce operons attenuates Mycobacterium tuberculosis virulence. Microbes Infect 7 : 325-334.
17. Gordon SV, Brosch R, Billault A, Garnier T, Eiglmeier K Cole ST (1999) Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol Microbiol 32 : 643-655.
18. Hanif SNM, El-Shammy AM, Al-Attiyah R Mustafa AS (2008) Whole blood assays to identify Th1 cell antigens and peptides encoded by Mycobacterium tuberculosis-specific RD1 genes. Med Prin Pract 17 : 244-249.
19. Hesseling AC, Rabie H, Marais BJ et al. 2006) Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis 42 : 548-558.
20. Hsu T, Hingley-Wilson SM, Chen B et al. 2003) The primary mechanism of attenuation of Bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. P Natl Acad Sci USA 100 : 12420-12425.
21. Hussain R, Talal N, Shahid F Dawood G (2007) Longitudinal tracking of cytokines after acute exposure to tuberculosis: association of distinct cytokine patterns with protection and disease development. Clin Vaccine Immunol 14 : 1578-1586.
22. Jamil B, Shahid F, Hasa Z, Nasir N, Razzaki T, Dawood G Hussain R (2007) Interferon γ/IL-10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis. Tuberculosis 87 : 279-287.
23. Lewis KN, Liao R, Guinn KM, Hickey MJ, Smith S, Behr MA Sherman DR (2003) Deletion of RD1 from Mycobacterium tuberculosis mimics Bacille Calmette-Guérin attenuation. J Infect Dis 187 : 117-123.
24. Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA Lalvani A (2004) Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 364 : 2196-2203.
25. Liu XQ, Dosanjh D, Varia H, Ewer K, Cockle P, Pasvol G Lalvani A (2004) Evaluation of T-cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection. Infect Immun 72 : 2574-2581.
26. Lönnroth K Raviglione M (2008) Global epidemiology of tuberculosis: prospects for control. Semin Respir Crit Care Med 29 : 481-491.
27. Marchand I, Emahé E, Clérici T, Saiag P Chevallier B (2008) Disseminated BCG infection revealing X-linked severe combined immunodeficiency. Ann Dermatol Venereol 135 : 587-590.
28. Moura EP, Toledo VP, Oliveira MH, Spíndola-de-Miranda S, Andrade HM Guimarães TM (2004) Pulmonary tuberculosis: evaluation of interferon-gamma levels as an immunological healing marker based on the response to the Bacillus Calmette-Guerin. Mem I Oswaldo Cruz 99 : 283-287.
29. Murray PJ, Wang L, Onufryk C, Tepper RI Young RA (1997) T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol 158 : 315-321.
30. Mustafa AS (2005a) Progress towards the development of new anti-tuberculosis vaccines. Focus on Tuberculosis Research (Smithe T, ed), pp. 47-76. Nova Science Publishers Inc.
31. Mustafa AS (2005b) Recombinant and synthetic peptides to identify Mycobacterium tuberculosis antigens and epitopes of diagnostic and vaccine relevance. Tuberculosis 85 : 367-376.
32. Mustafa AS (2009a) Th1 cell reactivity and HLA-DR binding prediction for promiscuous recognition of MPT63 (Rv1926c), a major secreted protein of Mycobacterium tuberculosis. Scand J Immunol 69 : 213-222.
33. Mustafa AS (2009b) HLA-promiscuous Th1-cell reactivity of MPT64 (Rv1980c), a major secreted antigen of Mycobacterium tuberculosis, in healthy subjects. Med Prin Pract 18 : 385-392.
34. Mustafa AS (2009c) Vaccine potential of Mycobacterium tuberculosis-specific genomic regions: in vitro studies in humans. Expert Rev Vaccines 8 : 1309-1312.
35. Mustafa AS, Shaban FA, Abal AT, Al-Attiyah R, Wiker HG, Lundin KE, Oftung F Huygen K (2000) Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines. Infect Immun 68 : 3933-3940.
36. Mustafa AS, Skeiky YA, Al-Attiyah R, Alderson MR, Hewinson RG Vordermeier HM (2006) Immunogenicity of Mycobacterium tuberculosis antigens in Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle. Infect Immun 74 : 4566-4572.
37. Mustafa AS, Al-Attiyah R, Hanif SN Shaban FA (2008) Efficient testing of large pools of Mycobacterium tuberculosis RD1 peptides and identification of major antigens and immunodominant peptides recognized by human Th1 cells. Clin Vaccine Immunol 15 : 916-924.
38. Okkels LM, Brock I, Follmann F, Agger EM, Arend SM, Ottenhoff TH, Oftung F, Rosenkrands I Andersen P (2003) PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE family. Infect Immun 71 : 6116-6123.
39. Primm TP, Lucero CA Falkinham III. JO (2004) Health impacts of environmental mycobacteria. Clin Microbiol Rev 17 : 98-106.
40. Rao V, Dhar N, Shakila H et al. 2005) Increased expression of Mycobacterium tuberculosis 19 kDa lipoprotein obliterates the protective efficacy of BCG by polarizing host immune responses to the Th2 subtype. Scand J Immunol 61 : 410-417.
41. Sahiratmadja E, Alisjahbana B, de Boer T et al. 2007) Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect Immun 75 : 820-829.
42. Salina T Morozova T (2004) Production of gamma-interferon by blood mononuclear cells in patients with various types of a tuberculous process. Probl Tuberk Bolezn Legk 10 : 19-21.
43. Senaratne RH, Sidders B, Sequeira P et al. 2008) Mycobacterium tuberculosis strains disrupted in mce3 and mce4 operons are attenuated in mice. J Med Microbiol 57 : 164-170.
44. Skeiky YA Sadoff JC (2006) Advances in tuberculosis vaccine strategies. Nat Rev Microbiol 4 : 469-476.
45. Smith R (2009) Eradication of tuberculosis by 2050 impossible without new vaccine. Br Med J 338 : b1291.
46. Turner J, Gonzalez-Juarrero M, Ellis DL, Basaraba RJ, Kipnis A, Orme IM Cooper AM (2002) In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J Immunol 169 : 6343-6351.
47. Van Crevel R, Ottenhoff THM van der Meer JWM (2002) Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev 15 : 294-309.
48. Wassie L Demissie A VACSEL Study Group et al. 2008) Ex vivo cytokine mRNA levels correlate with changing clinical status of Ethiopian TB patients and their contacts over time. PLoS One 3 : e1522.
49. WHO Report (2009) Global Tuberculosis Control: Epidemiology, Strategy, Financing (Publication no. WHO/HTM/TB/2009.411). World Health Organization